Home › Companies › TG Therapeutics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and TG Therapeutics, Inc.’s Form 8-K, filed June 12, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 11, 2026: 8 items on TG Therapeutics, Inc.’s Form 8-K, filed June 12, 2026: 8 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore TG Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are TG Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael S. Weiss | 72,172,630 | -- | -- | 9,260,279 | 31,570,505 | 89% | Not verified | — |
| Elect Director: Laurence N. Charney | 68,135,448 | -- | -- | 13,297,461 | 31,570,505 | 84% | Not verified | — |
| Elect Director: Yann Echelard | 64,110,661 | -- | -- | 17,322,248 | 31,570,505 | 79% | Not verified | — |
| Elect Director: Kenneth Hoberman | 53,354,717 | -- | -- | 28,078,192 | 31,570,505 | 66% | Not verified | — |
| Elect Director: Daniel Hume | 63,979,535 | -- | -- | 17,453,374 | 31,570,505 | 79% | Not verified | — |
| Elect Director: Sagar Lonial, MD | 44,666,544 | -- | -- | 36,766,365 | 31,570,505 | 54.9% | Not verified | — |
| 2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 112,329,330 | 531,758 | 142,326 | -- | -- | 99.5% | Not verified | — |
| 3. The advisory vote to approve the compensation of the Company's named executive officers | 31,905,837 | 48,858,169 | 668,903 | -- | 31,570,505 | 40% | Not verified | — |
Source: TG Therapeutics, Inc., Form 8-K, filed with the SEC on June 12, 2026 — read the filing on EDGAR.
Each item below shows how the 361 asset managers that disclosed a TG Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Daniel Hume
TG Therapeutics, Inc.’s own tally for this item (“Elect Director: Daniel Hume”): 63,979,535 for, 17,453,374 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 32,405,877 for, 8,337,648 withheld, 392,432 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,273,516 | 0 | 189 | 1,398,996 | Mixed |
| BlackRock | 7,168,562 | 0 | 0 | 0 | For |
| State Street | 3,632,447 | 0 | 0 | 4,697 | For |
| Fidelity | 2,223,353 | 0 | 0 | 99,191 | For |
| Legg Mason | 0 | 0 | 0 | 1,523,579 | Withhold |
| TIAA | 0 | 0 | 0 | 1,521,720 | Withhold |
| PROFESSIONALLY MANAGED PORTFOLIOS | 1,300,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 1,138,044 | Withhold |
| Manager Directed Portfolios | 972,563 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 410,690 | Withhold |
| Equitable | 206,273 | 0 | 0 | 154,570 | Mixed |
| Jackson National | 0 | 0 | 307,351 | 0 | Abstain |
| Voya | 301,568 | 0 | 0 | 0 | For |
| Goldman Sachs | 278,199 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 235,816 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 207,096 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 174,957 | Withhold |
| Lincoln Financial | 96,000 | 0 | 0 | 60,745 | Mixed |
| First Trust | 0 | 0 | 0 | 146,209 | Withhold |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 131,112 | Withhold |
| Brighthouse | 0 | 0 | 0 | 128,449 | Withhold |
| BNY Mellon | 0 | 0 | 0 | 120,181 | Withhold |
| Principal | 0 | 0 | 0 | 117,626 | Withhold |
| ProShares | 0 | 0 | 0 | 97,149 | Withhold |
| Empower | 0 | 0 | 0 | 97,034 | Withhold |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 7 wordings of this item as funds reported it.
66% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kenneth Hoberman
TG Therapeutics, Inc.’s own tally for this item (“Elect Director: Kenneth Hoberman”): 53,354,717 for, 28,078,192 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 66% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 26,641,075 for, 6,934,900 withheld, 7,559,982 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,576,805 | 0 | 180 | 95,716 | For |
| BlackRock | 301,375 | 0 | 6,867,187 | 0 | Abstain |
| State Street | 3,632,447 | 0 | 0 | 4,697 | For |
| Fidelity | 6,601 | 0 | 0 | 2,315,943 | Withhold |
| Legg Mason | 1,510,647 | 0 | 0 | 12,932 | For |
| TIAA | 1,521,720 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 1,300,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 1,138,044 | Withhold |
| Manager Directed Portfolios | 972,563 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 410,690 | Withhold |
| Equitable | 38,000 | 0 | 0 | 322,843 | Mixed |
| Jackson National | 0 | 0 | 307,351 | 0 | Abstain |
| Voya | 0 | 0 | 0 | 301,568 | Withhold |
| Goldman Sachs | 278,199 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 235,816 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 0 | 207,096 | Withhold |
| Dimensional | 0 | 0 | 0 | 174,957 | Withhold |
| Lincoln Financial | 96,000 | 0 | 0 | 60,745 | Mixed |
| First Trust | 0 | 0 | 0 | 146,209 | Withhold |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 131,112 | Withhold |
| Brighthouse | 0 | 0 | 0 | 128,449 | Withhold |
| BNY Mellon | 0 | 0 | 0 | 120,181 | Withhold |
| Principal | 0 | 0 | 0 | 117,626 | Withhold |
| ProShares | 0 | 0 | 0 | 97,149 | Withhold |
| Empower | 0 | 0 | 0 | 97,034 | Withhold |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 8 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Laurence Charney
TG Therapeutics, Inc.’s own tally for this item (“Elect Director: Laurence N. Charney”): 68,135,448 for, 13,297,461 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 36,779,568 for, 3,964,001 withheld, 392,388 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,576,840 | 0 | 145 | 95,716 | For |
| BlackRock | 7,168,562 | 0 | 0 | 0 | For |
| State Street | 3,632,447 | 0 | 0 | 4,697 | For |
| Fidelity | 2,223,353 | 0 | 0 | 99,191 | For |
| Legg Mason | 1,510,647 | 0 | 0 | 12,932 | For |
| TIAA | 1,521,720 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 1,300,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 1,138,044 | Withhold |
| Manager Directed Portfolios | 972,563 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 410,690 | Withhold |
| Equitable | 244,273 | 0 | 0 | 116,570 | Mixed |
| Jackson National | 0 | 0 | 307,351 | 0 | Abstain |
| Voya | 301,568 | 0 | 0 | 0 | For |
| Goldman Sachs | 278,199 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 235,816 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 207,096 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 174,957 | Withhold |
| Lincoln Financial | 96,000 | 0 | 0 | 60,745 | Mixed |
| First Trust | 0 | 0 | 0 | 146,209 | Withhold |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 131,112 | Withhold |
| Brighthouse | 0 | 0 | 0 | 128,449 | Withhold |
| BNY Mellon | 0 | 0 | 0 | 120,181 | Withhold |
| Principal | 0 | 0 | 0 | 117,626 | Withhold |
| ProShares | 0 | 0 | 0 | 97,149 | Withhold |
| Empower | 0 | 0 | 0 | 97,034 | Withhold |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 7 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michael S. Weiss
TG Therapeutics, Inc.’s own tally for this item (“Elect Director: Michael S. Weiss”): 72,172,630 for, 9,260,279 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 38,704,872 for, 2,321,350 withheld, 109,735 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,537,524 | 0 | 101 | 135,076 | For |
| BlackRock | 7,168,562 | 0 | 0 | 0 | For |
| State Street | 3,627,392 | 0 | 0 | 9,752 | For |
| Fidelity | 2,314,244 | 0 | 0 | 8,300 | For |
| Legg Mason | 1,510,647 | 0 | 0 | 12,932 | For |
| TIAA | 1,521,720 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 1,300,000 | 0 | 0 | 0 | For |
| Charles Schwab | 1,138,044 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 972,563 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 410,690 | Withhold |
| Equitable | 244,273 | 0 | 0 | 116,570 | Mixed |
| Jackson National | 281,864 | 0 | 25,487 | 0 | Mixed |
| Voya | 301,568 | 0 | 0 | 0 | For |
| Goldman Sachs | 278,199 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 235,816 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 207,096 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 174,957 | Withhold |
| Lincoln Financial | 96,000 | 0 | 0 | 60,745 | Mixed |
| First Trust | 0 | 0 | 0 | 146,209 | Withhold |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 131,112 | Withhold |
| Brighthouse | 0 | 0 | 0 | 128,449 | Withhold |
| BNY Mellon | 120,181 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 117,626 | Withhold |
| ProShares | 0 | 0 | 0 | 97,149 | Withhold |
| Empower | 0 | 0 | 0 | 97,034 | Withhold |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 8 wordings of this item as funds reported it.
54.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Sagar Lonial, MD
TG Therapeutics, Inc.’s own tally for this item (“Elect Director: Sagar Lonial, MD”): 44,666,544 for, 36,766,365 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 54.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 20,309,708 for, 12,888,183 withheld, 7,938,066 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,273,421 | 0 | 284 | 1,398,996 | Mixed |
| BlackRock | 0 | 0 | 7,168,562 | 0 | Abstain |
| State Street | 8,330 | 0 | 0 | 3,628,814 | Withhold |
| Fidelity | 2,148,402 | 0 | 0 | 174,142 | Mixed |
| Legg Mason | 0 | 0 | 0 | 1,523,579 | Withhold |
| TIAA | 0 | 0 | 0 | 1,521,720 | Withhold |
| PROFESSIONALLY MANAGED PORTFOLIOS | 1,300,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 1,138,044 | Withhold |
| Manager Directed Portfolios | 972,563 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 410,690 | Withhold |
| Equitable | 0 | 0 | 0 | 360,843 | Withhold |
| Jackson National | 0 | 0 | 307,351 | 0 | Abstain |
| Voya | 0 | 0 | 0 | 301,568 | Withhold |
| Goldman Sachs | 278,199 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 235,816 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 0 | 207,096 | Withhold |
| Dimensional | 0 | 0 | 0 | 174,957 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 156,745 | Withhold |
| First Trust | 0 | 0 | 0 | 146,209 | Withhold |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 131,112 | Withhold |
| Brighthouse | 0 | 0 | 0 | 128,449 | Withhold |
| BNY Mellon | 0 | 0 | 0 | 120,181 | Withhold |
| Principal | 0 | 0 | 0 | 117,626 | Withhold |
| ProShares | 0 | 0 | 0 | 97,149 | Withhold |
| Empower | 0 | 0 | 0 | 97,034 | Withhold |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 7 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Yann Echelard
TG Therapeutics, Inc.’s own tally for this item (“Elect Director: Yann Echelard”): 64,110,661 for, 17,322,248 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 32,405,878 for, 8,337,648 withheld, 392,431 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,273,517 | 0 | 188 | 1,398,996 | Mixed |
| BlackRock | 7,168,562 | 0 | 0 | 0 | For |
| State Street | 3,632,447 | 0 | 0 | 4,697 | For |
| Fidelity | 2,223,353 | 0 | 0 | 99,191 | For |
| Legg Mason | 0 | 0 | 0 | 1,523,579 | Withhold |
| TIAA | 0 | 0 | 0 | 1,521,720 | Withhold |
| PROFESSIONALLY MANAGED PORTFOLIOS | 1,300,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 1,138,044 | Withhold |
| Manager Directed Portfolios | 972,563 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 410,690 | Withhold |
| Equitable | 206,273 | 0 | 0 | 154,570 | Mixed |
| Jackson National | 0 | 0 | 307,351 | 0 | Abstain |
| Voya | 301,568 | 0 | 0 | 0 | For |
| Goldman Sachs | 278,199 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 235,816 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 207,096 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 174,957 | Withhold |
| Lincoln Financial | 96,000 | 0 | 0 | 60,745 | Mixed |
| First Trust | 0 | 0 | 0 | 146,209 | Withhold |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 131,112 | Withhold |
| Brighthouse | 0 | 0 | 0 | 128,449 | Withhold |
| BNY Mellon | 0 | 0 | 0 | 120,181 | Withhold |
| Principal | 0 | 0 | 0 | 117,626 | Withhold |
| ProShares | 0 | 0 | 0 | 97,149 | Withhold |
| Empower | 0 | 0 | 0 | 97,034 | Withhold |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 9 wordings of this item as funds reported it.
40% Majority: no · of votes cast
Description as filed by funds: An advisory vote to approve the compensation of our named executive officers.
TG Therapeutics, Inc.’s own tally for this item (“3. The advisory vote to approve the compensation of the Company's named executive officers”): 31,905,837 for, 48,858,169 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 40% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,581,444 | 10,091,251 | 6 | 0 | Mixed |
| BlackRock | 0 | 7,168,562 | 0 | 0 | Against |
| State Street | 8,330 | 3,628,814 | 0 | 0 | Against |
| Fidelity | 0 | 2,322,544 | 0 | 0 | Against |
| Legg Mason | 0 | 1,523,579 | 0 | 0 | Against |
| TIAA | 1,521,720 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 1,300,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,138,044 | 0 | 0 | Against |
| Manager Directed Portfolios | 972,563 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 410,690 | 0 | 0 | Against |
| Equitable | 0 | 360,843 | 0 | 0 | Against |
| Jackson National | 0 | 307,351 | 0 | 0 | Against |
| Voya | 0 | 301,568 | 0 | 0 | Against |
| Goldman Sachs | 278,199 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 235,816 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 207,096 | 0 | 0 | Against |
| Dimensional | 0 | 174,957 | 0 | 0 | Against |
| Lincoln Financial | 0 | 156,745 | 0 | 0 | Against |
| First Trust | 0 | 146,209 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 0 | 131,112 | 0 | 0 | Against |
| Brighthouse | 0 | 99,271 | 29,178 | 0 | Mixed |
| BNY Mellon | 0 | 120,181 | 0 | 0 | Against |
| Principal | 0 | 117,626 | 0 | 0 | Against |
| ProShares | 0 | 97,149 | 0 | 0 | Against |
| Empower | 0 | 97,034 | 0 | 0 | Against |
Fund voting reports, all 86 managers: 10,836,071 for, 30,256,553 against, 29,184 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 13,921 | 5,921,985 | 0 | 0 | Against |
| BlackRock | 9,440 | 4,526,900 | 0 | 0 | Against |
| Clearbridge Investments, LLC | 0 | 3,127,235 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 2,564,065 | 0 | 0 | Against |
| CONGRESS ASSET MANAGEMENT CO | 2,322,397 | 14,750 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 0 | 1,610,023 | 0 | 0 | Against |
| Nuveen | 1,568,743 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 1,500,390 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,301,791 | 0 | 0 | Against |
| Vanguard | 1,077,600 | 135,905 | 0 | 0 | Mixed |
| Northern Trust | 0 | 971,340 | 0 | 0 | Against |
| T. Rowe Price | 0 | 699,316 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 0 | 664,762 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 650,840 | 0 | 0 | Against |
| Invesco | 0 | 555,333 | 0 | 0 | Against |
| Two Sigma | 0 | 520,226 | 0 | 0 | Against |
| BANK OF MONTREAL /CAN/ | 0 | 504,593 | 0 | 0 | Against |
| Goldman Sachs | 459,081 | 11,614 | 0 | 0 | For |
| Voya | 0 | 418,672 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 363,204 | 0 | 0 | Against |
| 683 Capital Management, LLC | 0 | 328,175 | 0 | 0 | Against |
| BESSEMER INVESTMENT MANAGEMENT LLC | 0 | 262,224 | 0 | 0 | Against |
| WELLS FARGO CLEARING SERVICES, LLC | 248,613 | 0 | 0 | 0 | For |
| Bridgewater | 0 | 232,065 | 0 | 0 | Against |
| Soleus Capital Management, L.P. | 231,772 | 0 | 0 | 0 | For |
Institutional-manager reports, all 298 managers: 8,208,193 for, 30,078,495 against, 17,956 abstained, 1,583 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026.
TG Therapeutics, Inc.’s own tally for this item (“2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 112,329,330 for, 531,758 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of TG Therapeutics, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 89 asset managers below reported 41,036,537 for, 56,542 against, 34,178 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,672,695 | 6 | 0 | 0 | For |
| BlackRock | 7,168,562 | 0 | 0 | 0 | For |
| State Street | 3,637,144 | 0 | 0 | 0 | For |
| Fidelity | 2,322,544 | 0 | 0 | 0 | For |
| Legg Mason | 1,523,579 | 0 | 0 | 0 | For |
| TIAA | 1,521,720 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 1,300,000 | 0 | 0 | 0 | For |
| Charles Schwab | 1,138,044 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 972,563 | 0 | 0 | 0 | For |
| T. Rowe Price | 410,690 | 0 | 0 | 0 | For |
| Equitable | 360,843 | 0 | 0 | 0 | For |
| Jackson National | 307,351 | 0 | 0 | 0 | For |
| Voya | 301,568 | 0 | 0 | 0 | For |
| Goldman Sachs | 278,199 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 235,816 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 207,096 | 0 | 0 | 0 | For |
| Dimensional | 174,957 | 0 | 0 | 0 | For |
| Lincoln Financial | 156,745 | 0 | 0 | 0 | For |
| First Trust | 146,209 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 131,112 | 0 | 0 | 0 | For |
| Brighthouse | 99,271 | 0 | 29,178 | 0 | Mixed |
| BNY Mellon | 120,181 | 0 | 0 | 0 | For |
| Principal | 117,626 | 0 | 0 | 0 | For |
| ProShares | 97,149 | 0 | 0 | 0 | For |
| Empower | 97,034 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 153,083,580 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.89% |
| 2 | BlackRock | 4.68% |
| 3 | State Street | 2.38% |
| 4 | Fidelity | 1.52% |
| 5 | Legg Mason | 1.00% |
| 6 | TIAA | 0.99% |
| 7 | PROFESSIONALLY MANAGED PORTFOLIOS | 0.85% |
| 8 | Charles Schwab | 0.74% |
| 9 | Manager Directed Portfolios | 0.64% |
| 10 | T. Rowe Price | 0.27% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 3.88% |
| 2 | BlackRock | 2.96% |
| 3 | Clearbridge Investments, LLC | 2.04% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.67% |
| 5 | CONGRESS ASSET MANAGEMENT CO | 1.53% |
| 6 | PICTET ASSET MANAGEMENT SA | 1.05% |
| 7 | Nuveen | 1.02% |
| 8 | Hood River Capital Management LLC | 0.98% |
| 9 | Charles Schwab | 0.85% |
| 10 | Vanguard | 0.79% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 14.54% | 13F |
| Vanguard Group | 10.35% | 13F |
| State Street | 5.65% | 13F |
| Geode Capital | 2.29% | 13F |
| Goldman Sachs | 2.01% | 13F |
| Citadel Advisors | 1.60% | 13F |
| Two Sigma | 1.01% | 13F |
| Morgan Stanley | 0.98% | 13F |
| Northern Trust | 0.94% | 13F |
| Charles Schwab | 0.85% | 13F |
Percentages above are of 153,083,580 shares outstanding, as reported by TG Therapeutics, Inc. on its Form 10-Q dated May 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TG Therapeutics, Inc.’s 10-Q dated May 1, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At TG Therapeutics, Inc.'s shareholder meeting held June 11, 2026, in the 2025-2026 proxy season, 361 asset managers reported how they voted on 8 ballot items in their SEC Form N-PX filings, covering 3,010 separate fund positions. On the most widely held item on that ballot — An advisory vote to approve the compensation of our named executive officers. — FOR was 40% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is not more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TG Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2026.
TG Therapeutics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.